Lower Risk of Infectious Deaths in Cardiac Transplant Patients Receiving Basiliximab Versus Anti-thymocyte Globulin as Induction Therapy

Author:

Mattei Marie Françoise,Redonnet Michel,Gandjbakhch Iradj,Bandini Annick Mouly,Billes Allain,Epailly Eric,Guillemain Romain,Lelong Bernard,Pol Annie,Treilhaud Michelle,Vermes Emmanuelle,Dorent Richard,Lemay Djamila,Blanc Anne Sandrine,Boissonnat Pascale

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference19 articles.

1. Effectivity of a T-cell–adapted induction therapy with anti-thymocyte globulin (Sangstat);Koch;J Heart Lung Transplant,2005

2. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center;Montoya;Clin Infect Dis,2001

3. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult transplant report—2003;Taylor;J Heart Lung Transplant,2003

4. Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study;Smart;J Heart Lung Transplant,1996

5. Lymphoproliferative disease after renal transplantation in Australia and New Zealand;Faull;Transplantation,2005

Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Induction Therapy: When and How;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

2. Detection and management of HLA sensitization in candidates for adult heart transplantation;The Journal of Heart and Lung Transplantation;2023-04

3. Basiliximab induction versus no induction in adult heart transplantation;Clinical Transplantation;2023-02-26

4. Review of Postoperative Care for Heart Transplant Recipients;Journal of Cardiothoracic and Vascular Anesthesia;2023-01

5. Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia;Frontiers in Immunology;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3